165 related articles for article (PubMed ID: 7004634)
1. Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma.
Cabanillas F; Rodriguez V; Bodey GP
Cancer Treat Rep; 1980; 64(8-9):933-7. PubMed ID: 7004634
[No Abstract] [Full Text] [Related]
2. [Clinical efficacy of four-drug combination treatment of adriamycin, vincristine, ifosfamide, and prednisolone for patients with malignant lymphoma, especially relapsed or refractory types (author's transl)].
Kimura I; Ohnoshi T; Oka A; Nakata Y; Hayashi K; Sato M; Nishihara R; Tanaka T; Sezaki T
Rinsho Ketsueki; 1980 Jun; 21(6):785-91. PubMed ID: 7463736
[No Abstract] [Full Text] [Related]
3. [Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
Sugimoto T; Matano S; Nishijima H; Kakuta K; Inamura K; Okamura T; Munemoto S; Satoh S
Gan To Kagaku Ryoho; 2007 Jan; 34(1):125-8. PubMed ID: 17220687
[TBL] [Abstract][Full Text] [Related]
4. [CAMBO-VIP for advanced diffuse large cell lymphoma (LSG classification)--a long-term follow-up study].
Okamoto M; Maruyama F; Tsuzuki M; Nomura T; Miyazaki H; Wakita M; Kojima H; Sobue R; Matsui T; Ino T
Gan To Kagaku Ryoho; 1994 Jan; 21(1):67-73. PubMed ID: 7507314
[TBL] [Abstract][Full Text] [Related]
5. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
[No Abstract] [Full Text] [Related]
6. What constitutes "improved prognosis"?
Canellos GP
J Clin Oncol; 2008 Apr; 26(12):1913-4. PubMed ID: 18421041
[No Abstract] [Full Text] [Related]
7. A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.
Davidson KL; Devaney MB; Tighe JE; Rogers SY; Dunlop DJ; Mackie MJ; Thomas RV; Johnson PR;
Haematologica; 2003 Dec; 88(12):1366-71. PubMed ID: 14687989
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
9. Non-hodgkins lymphoma.
Mead G; Woodcock J; Young C
Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
[No Abstract] [Full Text] [Related]
10. [Therapy of non-Hodgkin lymphomas with COP and COPP regimens (author's transl)].
Rubio-Félix D; Maicas M; Rubio-Vitaller A; Gil JL; Giralt M; Raichs A
Sangre (Barc); 1977; 22(5B):854-9. PubMed ID: 335544
[No Abstract] [Full Text] [Related]
11. [Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hematology and Hemotherapy].
López-Guillermo A; García-Conde J; Alvarez-Carmona AM; León P; Maldonado J; Alcalá A; Zubizarreta A; Sancho-Tello R; Carbonell F; Contreras E; Besses C; Hernando A; Fontanillas M; Montserrat E
Med Clin (Barc); 1998 May; 110(16):601-4. PubMed ID: 9656196
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate, cyclophosphamide and vincristine (MEV regimen) for non-Hodgkin's lymphoma.
Lauria F; Baccarani M; Fiacchini M; Gobbi M; Tura S
Eur J Cancer (1965); 1975 May; 11(5):343-9. PubMed ID: 1098915
[No Abstract] [Full Text] [Related]
13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
14. Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids.
Carbone PP; Spurr C; Schneiderman M; Scotto J; Holland JF; Shnider B
Cancer Res; 1968 May; 28(5):811-22. PubMed ID: 4870882
[No Abstract] [Full Text] [Related]
15. Recent advances in chemotherapy of lymphoma.
Lenhard RE; Owens AH
Johns Hopkins Med J; 1967 Aug; 121(2):136-40. PubMed ID: 5340335
[No Abstract] [Full Text] [Related]
16. [A case of secondary malignant lymphoma of the urinary bladder].
Yokoyama M; Kobayashi T; Kubo Y; Kageyama Y; Kihara K
Hinyokika Kiyo; 2006 Apr; 52(4):285-7. PubMed ID: 16686357
[TBL] [Abstract][Full Text] [Related]
17. [Increased blood cell destruction during vigorous regeneration of bone marrow after CAMBO-VIP chemotherapy for non-Hodgkin's lymphoma].
Maruyama F; Ezaki K; Okamoto M; Miyazaki H; Wakita M; Nomura T; Tsuzuki M; Kojima H; Sobue R; Matsui T
Rinsho Ketsueki; 1994 Feb; 35(2):114-9. PubMed ID: 7511181
[TBL] [Abstract][Full Text] [Related]
18. A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.
Schenkein DP; Roitman D; Miller KB; Morelli J; Stadtmauer E; Pecora AL; Cassileth P; Fernandez H; Cooper BW; Kutteh L; Lazarus HM
Biol Blood Marrow Transplant; 1997 Oct; 3(4):210-6. PubMed ID: 9360783
[TBL] [Abstract][Full Text] [Related]
19. COMLA chemotherapy for lymphoma.
Raich PC
Ann Intern Med; 1980 Sep; 93(3):509-10. PubMed ID: 7001970
[No Abstract] [Full Text] [Related]
20. Continuous infusion vincristine and bleomycin with high dose methotrexate for resistant non-Hodgkin's lymphoma.
Hollister D; Silver RT; Gordon B; Coleman M
Cancer; 1982 Nov; 50(9):1690-4. PubMed ID: 6180819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
